Particle therapy versus conventional radiotherapy for lung cancer
Referencias
Additional references
Baumert B G, Lomax A J, Miltchev V, Davis J B. A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. International journal of radiation oncology, biology, physics 2001;49(5):1439‐49.
Brada M, Pijls‐Johannesma M, De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. Journal of clinical oncology 2007;25(8):965‐70.
Chang J Y, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three‐dimensional conformal or intensity‐modulated radiation therapy in Stage I or Stage III non‐small‐cell lung cancer. International journal of radiation oncology, biology, physics 2006;65(4):1087‐96.
Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiotherapy and oncology 2001;61(3):287‐97.
Farray D, Mirkovic N, Albain K S. Multimodality therapy for stage III non‐small‐cell lung cancer. Journal of clinical oncology 2005;23(14):3257‐69.
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Annals of oncology 2007;18(3):581‐92.
Fogliata A, Bolsi A, Cozzi L. Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast. Radiotherapy and oncology 2002;62(2):137‐45.
Greco C, Wolden S. Current status of radiotherapy with proton and light ion beams. Cancer 2007;109(7):1227‐38.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and X‐ray therapy in locally advanced rectal cancer. Radiotherapy and oncology 1996;41(3):263‐72.
Isacsson U, Hagberg H, Johansson K A, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiotherapy and oncology 1997;45(1):63‐70.
Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiotherapy and oncology 2007;83(2):203‐13.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M J. Cancer statistics, 2007. CA: a cancer journal for clinicians 2007;57(1):43‐66.
Kim Y S, Yoon S M, Choi E K, Yi B Y, Kim J H, Ahn S D, et al. Phase II study of radiotherapy with three‐dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non‐small‐cell lung cancer. International journal of radiation oncology, biology, physics 2005;62(1):76‐81.
Krengli M, Hug E B, Adams J A, Smith A R, Tarbell N J, Munzenrider J E. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. International journal of radiation oncology, biology, physics 2005;61(2):583‐93.
Lee C H, Tait D, Nahum A E, Webb S. Comparison of proton therapy and conformal X‐ray therapy in non‐small cell lung cancer (NSCLC). The British journal of radiology 1999;72(863):1078‐84.
Lodge M, Pijls‐Johannesma M, Stirk L, Munro A J, De Ruysscher D, Jefferson T. A systematic literature review of the clinical and cost‐effectiveness of hadron therapy in cancer>. Radiotherapy and oncology 2007;83(2):110‐22.
Miralbell R, Crowell C, Suit H D. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. International journal of radiation oncology, biology, physics 1992;22(2):305‐10.
Miralbell R, Lomax A, Bortfeld T, Rouzaud M, Carrie C. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. International journal of radiation oncology, biology, physics 1997;38(3):477‐84.
Olsen D R, Bruland O S, Frykholm G, Norderhaug I N. Proton therapy ‐ A systematic review of clinical effectiveness. Radiotherapy and oncology 2007;83(2):123‐32.
Pijls‐Johannesma M, Grutters J P, Lambin P, Ruysscher D D. Particle therapy in lung cancer: Where do we stand?. Cancer treatment reviews 2008;34(3):259‐67.
Rubins J, Unger M, Colice G L. Follow‐up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence‐based clinical practice guideline (2nd edition). Chest 2007;132(3 Suppl):355S‐67S.
St Clair W H, Adams J A, Bues M, Fullerton B C, La Shell S, Kooy H M, et al. Advantage of protons compared to conventional X‐ray or IMRT in the treatment of a pediatric patient with medulloblastoma. International journal of radiation oncology, biology, physics 2004;58(3):727‐34.
Stroup D F, Berlin J A, Morton S C, Olkin I, Williamson G D, Rennie D, et al. Meta‐analysis of observational studies in epidemiology: a proposal for reporting. Meta‐analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008‐12.
Weber D C, Trofimov A V, Delaney T F, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. International journal of radiation oncology, biology, physics 2004;58(5):1596‐606.
Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, et al. The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors. International journal of radiation oncology, biology, physics 2000;48(1):277‐88.
